Hope, Strength, and Healing for families coping with a child cancer diagnosis

Meet Keaton Kiddo ~ Kyle

Meet Keaton super kiddo Kyle! Kyle is 16 years old and enjoys playing on his Nintendo switch. He also likes Star Wars, Disneyland, Mario series and Harry Potter. Kyle was first diagnosis with Pilocytic astrocytoma, a slow-growing tumor of the brain or spinal cord, when he was just 3 1/2 years old. After being in remission for 5 years, Kyle and his family found out in April of this year the devastating news that Kyle once again has a brain tumor.

Following his diagnosis, Kyle’s chemo treatment has unfortunately impacted his gross motor functioning and he is now using a power wheelchair to get around. Despite these challenges, Kyle remains a fighter, a strong young man and a warrior. As he endures his battle against childhood cancer for the second time, Kyle’s mom and sister continue to be a huge support for him. With an hour and a half commute, round trip, for his weekly treatments, mom ensures that Kyle gets to his appointments and receives all of the care he needs.

During a recent visit to a local partnering hospital, our Keaton’s Family Navigator Team was able to meet Kyle and his mom to hand-deliver their family’s Hope Chest and a gas card to support with their long commute back home. After meeting with them, Mom shared these wonderful photos of Kyle with the gifts from the Hope Chest along with his favorite quote: “Secretly hoping Cancer gives me superpowers.”

You are not in this fight alone Kyle!

Honoring Keaton’s Angel – Abel

We remember our Keaton’s angel, Abel. A bright young man who thrived in school. His hope was to one day go to college and work towards his success. With his caring heart and love for his family, Abel left an impact on everyone he met and will be sincerely missed. We celebrate Abel’s life and legacy, honoring his journey.

Read More ›

Meet Keaton’s Kiddo – Colby

At just 10 years old, on April 29, 2021, Keaton’s Kiddo Colby was diagnosed with T-Cell Acute Lymphoblastic Leukemia (ALL), which represents around 12%-15% of pediatric leukemia patients.

Read More ›